193 related articles for article (PubMed ID: 35876964)
1. Feasibility and preliminary efficacy of iConquerFear: a self-guided digital intervention for fear of cancer recurrence.
Smith A'; Bamgboje-Ayodele A; Jegathees S; Butow P; Klein B; Salter M; Turner J; Fardell J; Thewes B; Sharpe L; Beatty L; Pearce A; Beith J; Costa D; Rincones O; Wu VS; Garden FL; Kiely BE; Lim K; Morstyn L; Hanley B; Hodgkin R; Beattie A; Girgis A
J Cancer Surviv; 2024 Apr; 18(2):425-438. PubMed ID: 35876964
[TBL] [Abstract][Full Text] [Related]
2. Development and usability evaluation of an online self-management intervention for fear of cancer recurrence (iConquerFear).
Smith AB; Bamgboje-Ayodele A; Butow P; Klein B; Turner J; Sharpe L; Fardell J; Beatty L; Pearce A; Thewes B; Beith J; ; Girgis A
Psychooncology; 2020 Jan; 29(1):98-106. PubMed ID: 31483911
[TBL] [Abstract][Full Text] [Related]
3. Study protocol: a randomized controlled trial comparing the efficacy of therapist guided internet-delivered cognitive therapy (TG-iConquerFear) with augmented treatment as usual in reducing fear of cancer recurrence in Danish colorectal cancer survivors.
Lyhne JD; Smith A'B; Frostholm L; Fink P; Jensen LH
BMC Cancer; 2020 Mar; 20(1):223. PubMed ID: 32178640
[TBL] [Abstract][Full Text] [Related]
4. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
[TBL] [Abstract][Full Text] [Related]
5. ConquerFear-Group: A randomized controlled trial of an online-delivered group-based psychological intervention for fear of cancer recurrence in breast cancer survivors.
Tauber NM; O'Toole MS; Jensen AB; Butow PN; Thewes B; Elkjaer E; Knutzen S; von Heymann A; Johansen C; Zachariae R
Psychooncology; 2023 Sep; 32(9):1424-1432. PubMed ID: 37489745
[TBL] [Abstract][Full Text] [Related]
6. Novel Clinician-Lead Intervention to Address Fear of Cancer Recurrence in Breast Cancer Survivors.
Liu J; Butow P; Bui KT; Serafimovska A; Costa DSJ; Kiely BE; Hui MN; Goodwin A; McNeil CM; Beith JM
JCO Oncol Pract; 2021 Jun; 17(6):e774-e784. PubMed ID: 33571035
[TBL] [Abstract][Full Text] [Related]
7. CBT-based Online Self-help Training to Reduce Fear and Distress After Cancer (CAREST Randomized Trial): 24 Months Follow-up Using Latent Growth Models and Latent Class Analysis.
van Helmondt SJ; Lodder P; van Woezik R; de Vries J; van der Lee ML
Ann Behav Med; 2023 Aug; 57(9):787-799. PubMed ID: 37078920
[TBL] [Abstract][Full Text] [Related]
8. Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial.
Johns SA; Stutz PV; Talib TL; Cohee AA; Beck-Coon KA; Brown LF; Wilhelm LR; Monahan PO; LaPradd ML; Champion VL; Miller KD; Giesler RB
Cancer; 2020 Jan; 126(1):211-218. PubMed ID: 31539169
[TBL] [Abstract][Full Text] [Related]
9. A novel clinician-delivered intervention to reduce fear of recurrence in breast cancer survivors: Results from a Phase I/II implementation study (CIFeR_2).
Liu J; He S; Butow P; Shaw J; McHardy CJ; Harris G; Serafimovska A; Butt Z; Beith J
Psychooncology; 2023 Dec; 32(12):1930-1938. PubMed ID: 37955600
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate, and Colorectal Cancer Survivors: The SWORD Study, a Randomized Controlled Trial.
van de Wal M; Thewes B; Gielissen M; Speckens A; Prins J
J Clin Oncol; 2017 Jul; 35(19):2173-2183. PubMed ID: 28471726
[TBL] [Abstract][Full Text] [Related]
11. Psychological intervention (ConquerFear) for treating fear of cancer recurrence: mediators and moderators of treatment efficacy.
Sharpe L; Turner J; Fardell JE; Thewes B; Smith AB; Gilchrist J; Beith J; Girgis A; Tesson S; Day S; Grunewald K; Butow P;
J Cancer Surviv; 2019 Oct; 13(5):695-702. PubMed ID: 31347010
[TBL] [Abstract][Full Text] [Related]
12. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence.
Fardell JE; Jones G; Smith AB; Lebel S; Thewes B; Costa D; Tiller K; Simard S; Feldstain A; Beattie S; McCallum M; ; Butow P
Psychooncology; 2018 Feb; 27(2):492-499. PubMed ID: 28755462
[TBL] [Abstract][Full Text] [Related]
13. Protocol of an implementation study of a clinician intervention to reduce fear of recurrence in cancer survivors (CIFeR_2 implementation study).
Liu J; Serafimovska A; He S; Butow P; Shaw J; McHardy CJ; Harris G; Butt Z; Beith J
BMC Med Educ; 2023 May; 23(1):312. PubMed ID: 37147706
[TBL] [Abstract][Full Text] [Related]
14. Measuring fear of cancer recurrence in survivors of childhood cancer: Development and preliminary validation of the Fear of Cancer Recurrence Inventory (FCRI)-Child and Parent versions.
Tutelman PR; Chambers CT; Heathcote LC; Fernandez CV; Flanders A; Patton M; Schulte FSM; Guilcher GMT; Simard S; MacLeod J; Stern M
Psychooncology; 2022 Jun; 31(6):911-919. PubMed ID: 35018689
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.
Burm R; Thewes B; Rodwell L; Kievit W; Speckens A; van de Wal M; Prins J
BMC Cancer; 2019 May; 19(1):462. PubMed ID: 31096934
[TBL] [Abstract][Full Text] [Related]
16. Fear of cancer recurrence among Chinese cancer survivors: Prevalence and associations with metacognition and neuroticism.
Ng DWL; Kwong A; Suen D; Chan M; Or A; Ng SS; Foo CC; Fielding BFS; Lam WWT
Psychooncology; 2019 Jun; 28(6):1243-1251. PubMed ID: 30932279
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of eye movement desensitization and reprocessing therapy for fear of cancer recurrence among cancer survivors: a randomized single-case experimental design.
Bruin J; van Rood YR; Peeters KCMJ; de Roos C; Tanious R; Portielje JEA; Gelderblom H; Hinnen SCH
Eur J Psychotraumatol; 2023; 14(2):2203427. PubMed ID: 37144665
[TBL] [Abstract][Full Text] [Related]
18. Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.
Maheu C; Lebel S; Courbasson C; Lefebvre M; Singh M; Bernstein LJ; Muraca L; Benea A; Jolicoeur L; Harris C; Ramanakumar AV; Ferguson S; Sidani S
BMC Cancer; 2016 Apr; 16():291. PubMed ID: 27112319
[TBL] [Abstract][Full Text] [Related]
19. ConquerFear-group: Feasibility study with pilot results of a psychological intervention for fear of cancer recurrence delivered in groups.
Tauber NM; Zachariae R; Jensen AB; Thewes B; Skyt I; Elkjaer E; Butow PN; O'Toole MS
Psychooncology; 2022 Jan; 31(1):30-38. PubMed ID: 34289212
[TBL] [Abstract][Full Text] [Related]
20. Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study.
Lebel S; Maheu C; Lefebvre M; Secord S; Courbasson C; Singh M; Jolicoeur L; Benea A; Harris C; Fung MF; Rosberger Z; Catton P
J Cancer Surviv; 2014 Sep; 8(3):485-96. PubMed ID: 24756313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
